MNG760
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- OXIDATIVE_PHOSPHORYLATION+0.297
- PANCREAS_BETA_CELLS+0.186
- NOTCH_SIGNALING+0.057
- KRAS_SIGNALING_DN+0.036
- MYC_TARGETS_V1+0.028
- UV_RESPONSE_UP-0.011
- APICAL_JUNCTION-0.020
- ADIPOGENESIS-0.021
- SPERMATOGENESIS-0.025
- CHOLESTEROL_HOMEOSTASIS-0.030
Top 10 suppressed
- INTERFERON_ALPHA_RESPONSE-0.565
- TNFA_SIGNALING_VIA_NFKB-0.519
- INTERFERON_GAMMA_RESPONSE-0.507
- IL6_JAK_STAT3_SIGNALING-0.457
- HYPOXIA-0.382
- ALLOGRAFT_REJECTION-0.381
- APOPTOSIS-0.372
- MITOTIC_SPINDLE-0.367
- INFLAMMATORY_RESPONSE-0.346
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.334
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR10899984 | — | — | 0.886 |
| 2 | MNG199 | — | — | 0.883 |
| 3 | SRR4296068 | — | cohortA1 | 0.879 |
| 4 | TCGA-37-4129-01A-01R-1100-07 | — | cohortSC | 0.875 |
| 5 | TCGA-E9-A245-01A-22R-A16F-07 | — | B | 0.862 |
| 6 | MNG341 | — | — | 0.857 |
| 7 | SRR1516072 | — | — | 0.856 |
| 8 | TCGA-E5-A4U1-01A-11R-A31N-07 | — | — | 0.856 |
| 9 | c8b9a438-4194-4243-a738-4e0bd4184f19 | — | — | 0.856 |
| 10 | MNG604 | — | — | 0.855 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 5 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| OXIDATIVE_PHOSPHORYLATION | 0.297 | Remibrutinib | — uncovered |
| PANCREAS_BETA_CELLS | 0.186 | Cobimetinib | — uncovered |
| NOTCH_SIGNALING | 0.057 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.036 | Remibrutinib | — uncovered |
| MYC_TARGETS_V1 | 0.028 | Inavolisib | — uncovered |